ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 973,03
-0,43%
Dow Jones
44 303,40
-0,99%
DAX
21 787,00
-0,58%
Brent Oil
74,565
0,00%
Bitcoin
96 399,96
-0,15%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Cencora Inc (COR)

  7. Cencora Inc (COR) Actualités

COR

Cencora (COR)

Cencora Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:COR
DateHeureSourceTitreSymboleSociété
07/02/202502h37Business WireCencora Announces Common Share Repurchase From Walgreens Boots AllianceNYSE:CORCencora Inc
07/02/202501h55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CORCencora Inc
05/02/202520h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CORCencora Inc
05/02/202512h34Edgar (US Regulatory)Form 8-K - Current reportNYSE:CORCencora Inc
05/02/202512h30Business WireCencora Reports Fiscal 2025 First Quarter ResultsNYSE:CORCencora Inc
04/02/202522h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CORCencora Inc
31/01/202521h59Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:CORCencora Inc
23/01/202522h27Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:CORCencora Inc
23/01/202522h21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CORCencora Inc
23/01/202522h17Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:CORCencora Inc
08/01/202513h30Business WireCencora Announces Date and Time for First Quarter Fiscal 2025 Earnings ReleaseNYSE:CORCencora Inc
02/01/202522h15Business WireCencora Completes Acquisition of Retina Consultants of AmericaNYSE:CORCencora Inc
09/12/202422h15Business WireCencora Closes $1.8 Billion Senior Notes OfferingNYSE:CORCencora Inc
04/12/202422h59Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:CORCencora Inc
03/12/202404h49Business WireCencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035NYSE:CORCencora Inc
02/12/202423h01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CORCencora Inc
02/12/202414h18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:CORCencora Inc
26/11/202422h30Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CORCencora Inc
26/11/202420h45Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:CORCencora Inc
06/11/202412h35Business WireCencora Reports Fiscal 2024 Fourth Quarter and Year End ResultsNYSE:CORCencora Inc
06/11/202412h30Business WireCencora Advances Specialty Leadership Through Acquisition of Retina Consultants of AmericaNYSE:CORCencora Inc
04/11/202414h30Business WireCencora Expands Enterprise Leadership Team with Two Senior AppointmentsNYSE:CORCencora Inc
01/10/202422h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CORCencora Inc
01/10/202413h30Business WireCencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings ReleaseNYSE:CORCencora Inc
20/08/202422h05Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NYSE:CORCencora Inc
15/08/202413h30Business WireCencora Elects Frank Clyburn to Its Board of DirectorsNYSE:CORCencora Inc
02/08/202400h08Business WireWalgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of ProceedsNYSE:CORCencora Inc
31/07/202422h12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:CORCencora Inc
31/07/202412h30Business WireCencora Reports Fiscal 2024 Third Quarter ResultsNYSE:CORCencora Inc
08/07/202414h35GlobeNewswire Inc.Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMDNYSE:CORCencora Inc
 Showing the most relevant articles for your search:NYSE:COR

Dernières Valeurs Consultées

EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
EU
HO
Thales
EU
CS
Axa
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
COIN
ETHUSD
Ethereum
EU
LR
Legrand
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces